Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro
Malignant pleural mesothelioma (MPM) is a tumour arising from pleural cavities with poor prognosis. Multimodality treatment with pemetrexed combined with cisplatin shows unsatisfying response-rates of 40%. The...
Source: BMC Cancer - Category: Cancer & Oncology Authors: Sabrina Borchert, Michael Wessolly, Jan Schmeller, Elena Mairinger, Jens Kollmeier, Thomas Hager, Thomas Mairinger, Thomas Herold, Daniel C. Christoph, Robert F. H. Walter, Wilfried E. E. Eberhardt, Till Pl önes, Jeremias Wohlschlaeger, Clemens Aigner, K Tags: Research article Source Type: research
More News: Alimta | Asbestosis | Cancer | Cancer & Oncology | Gastroschisis Repair | Genetics | Mesothelioma